Purpose: Hypofractionated stereotactic radiotherapy (HSRT) for refractory Cushing's disease may offer a condensed treatment schedule for patients with large tumors abutting the optic chiasm unsuitable for stereotactic radiosurgery (SRS). To-date only four patients have been treated by HSRT in the published literature. We investigated the feasibility, toxicity, and efficacy of HSRT compared to SRS.
Methods: After approval, we retrospectively evaluated patients treated at our institution for refractory Cushing's disease with SRS or HSRT. Study outcomes included biochemical control, time to biochemical control, local control, and late complications. Binary logistic regression and Cox proportional hazards regression evaluated predictors of outcomes.
Results: Patients treated with SRS (n = 9) and HSRT (n = 9) were enrolled with median follow-up of 3.4 years. Clinicopathologic details were balanced between the cohorts. Local control was 100% in both cohorts. Time to biochemical control was 6.6. and 9.5 months in the SRS and HSRT cohorts, respectively (p = 0.6258). Two patients in each cohort required salvage bilateral adrenalectomy. Late complications including secondary malignancy, radionecrosis, cranial nerve neuropathy, and optic pathway injury were minimal for either cohort.
Conclusions: HSRT is an appropriate treatment approach for refractory Cushing's disease, particularly for patients with large tumors abutting the optic apparatus. Prospective studies are needed to validate these findings and identify factors suggesting optimal fractionation approaches.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11102-019-00992-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mineralocorticoid Effects in Cushing's Disease: A Case Report.
Cureus
December 2024
Internal Medicine, Hospital Beatriz Ângelo, Unidade Local de Saúde de Loures/Odivelas, Loures, PRT.
Cushing's syndrome is a rare disease caused due to prolonged exposure to excess glucocorticoids. Although rare, diagnosing Cushing's syndrome is clinically significant as it allows tailored and timely management and significant reduction or even prevention of the comorbidities caused by cortisol excess. This report delineates the presentation of a 44-year-old female with refractory secondary hypertension and severe hypokalaemia, initially thought to be caused by hyperaldosteronism.
View Article and Find Full Text PDFSuccessful management of refractory Cushing's disease with severe hypercortisolemia using etomidate and temozolomide in post-surgical failure.
J R Coll Physicians Edinb
December 2024
Department of Endocrinology and Metabolism, Medical College and Hospital, Kolkata, India.
Article Synopsis
- * Surgery is the main treatment but often has limited success, leading to tumor recurrence and resistance to standard therapies, necessitating early and diverse treatment strategies.
- * A case study illustrates successful management of aggressive Cushing's disease using a combination of temozolomide and radiotherapy after surgery failed, alongside etomidate infusion for rapid cortisol reduction.
Cushing's Storm: A Case of Paraneoplastic Cushing's Syndrome-Induced Seizures Treated With Continuous Etomidate Infusion.
Cureus
September 2024
Pulmonary and Critical Care Medicine, University of Florida College of Medicine, Jacksonville, USA.
Article Synopsis
- A 67-year-old woman showed signs of abdominal pain, nausea, vomiting, and weight loss, leading to a diagnosis of paraneoplastic Cushing's syndrome caused by small lung cancer.
- Tests indicated high cortisol levels and low potassium, while the patient also experienced severe seizures despite taking several anti-epileptic drugs.
- The treatment involved using continuous etomidate infusion to reduce cortisol levels, highlighting how understanding medication side effects can help in managing complex medical conditions.
Intraoperative cone-beam computed tomography for catheter placement verification in pediatric hydrocephalus: technical note.
Childs Nerv Syst
November 2024
Department for Neurosurgery, Paracelsus Medical University, Christian Doppler Klinik, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Ventriculoperitoneal (VP) shunt placement, essential for managing hydrocephalus, often risks catheter malpositioning, especially in patients with small ventricles. We present a novel technique combining neuronavigation with intraoperative cone-beam computed tomography using the BrainLab system and Loop-X mobile imaging unit. This approach enables real-time verification of catheter placement by integrating preoperative MRI data with intraoperative CT imaging.
View Article and Find Full Text PDFRobot-assisted laparoscopic adrenalectomy: Extended application in children.
Eur J Surg Oncol
December 2024
Department of Pediatric Surgery and Urology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris Cité, Paris, France. Electronic address: https://twitter.com/hopital_necker.
Background: Minimally invasive surgery for paediatric adrenal tumours has evolved, but robot-assisted laparoscopic adrenalectomy (RALA) in children remains poorly studied. The current prospective study aims to demonstrate the safety and efficacy of RALA in treating children with adrenal tumours.
Methods: A prospective institutional analysis of children presenting with neuroblastic and endocrine tumours treated with RALA was undertaken over a six year-period.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!